Skip to main content
logo
Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
37.40
-0.20 (-0.53%)
At close: Oct 2, 2026, 4:00 PM EDT
37.34
-0.06 (-0.16%)
After-hours: Oct 2, 2026, 7:30 PM EDT

Definium Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
5,0251,31951014783590
Market Cap Growth
435.65%158.44%247.80%77.54%-85.99%-82.89%
Enterprise Value
3,9781,15123943-72444
Last Close Price
37.4013.396.963.662.2020.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
5.473.972.111.880.553.89
P/TBV Ratio
5.594.222.302.540.654.73

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.040.120.090.18--
Net Debt / Equity Ratio
-1.14-1.12-1.04-1.09-0.94-0.88
Net Debt / EBITDA Ratio
-2.232.42-2.141.43
Quick Ratio
6.906.177.053.097.9412.83
Current Ratio
6.956.297.253.228.1613.18
Return on Equity (ROE)
-64.09%-64.06%-68.01%-83.59%-37.54%-81.78%
Return on Assets (ROA)
-20.64%-28.01%-30.44%-39.84%-24.82%-47.63%
Return on Capital Employed (ROCE)
-23.80%-44.50%-39.50%-101.70%-43.60%-60.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.04%-13.93%-21.29%-65.24%-68.71%-15.76%
Buyback Yield / Dilution
-22.22%-26.78%-79.94%-26.90%-12.71%-54.25%